# Study of Zemplar iv in Patients With End Stage Chronic Kidney Disease, Undergoing Haemodialysis

> **NCT01084538** · — · COMPLETED · sponsor: **Abbott** · enrollment: 181 (actual)

## Conditions studied

- Parathyroid Hormone

## Interventions

- **DRUG:** Zemplar iv (paricalcitol iv)

## Key facts

- **NCT ID:** NCT01084538
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 181 (ACTUAL)
- **Last updated:** 2011-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01084538

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01084538, "Study of Zemplar iv in Patients With End Stage Chronic Kidney Disease, Undergoing Haemodialysis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01084538. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*